eISSN: 1897-4295
ISSN: 1734-9338
Advances in Interventional Cardiology/Postępy w Kardiologii Interwencyjnej
Current issue Archive Manuscripts accepted About the journal Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
2/2019
vol. 15
 
Share:
Share:
abstract:
Original paper

Peri-procedural hemostasis disorders in surgical and transcatheter aortic valve implantation

Katarzyna Czerwińska-Jelonkiewicz
1
,
Krzysztof Milewski
1
,
Piotr Buszman
1
,
Przemysław Kwasiborski
2
,
Krzysztof Sanetra
3
,
Wojciech Domaradzki
3
,
Paweł Buszman
1

  1. Center for Cardiovascular Research and Development, American Heart of Poland Inc., Bielsko-Biala, Poland
  2. Third Department of Internal Diseases and Cardiology, Warsaw Medical University, Warsaw, Poland
  3. First Department of Cardiac Surgery, American Heart of Poland Inc., Bielsko-Biala, Poland
Adv Interv Cardiol 2019; 15, 2 (56): 176–186
Online publish date: 2019/03/15
View full text Get citation
 
Introduction
Despite their high effectiveness, surgical aortic valve replacement (AVR) and transcatheter aortic valve implantation (TAVI) are associated with substantial risk of bleeding. Although procedure-related hemostasis disorders might be crucial for safety of both procedures, the amount of data on the peri-procedural status of hemostasis in patients with aortic valve stenosis (AS) subjected to AVR and TAVI is negligible.

Aim
To investigate the profile of peri-procedural hemostasis in elderly patients with AS, subjected to aortic valve prosthesis implantation.

Material and methods
We performed a prospective analysis of global hemostasis using ROTEM thromboelastometry and platelet reactivity assessment using impedance aggregometry in 30 consecutive patients ≥ 70 years old subjected to AVR and TAVI. All tests were performed within 24 h before, directly and 24 h after the procedures.

Results
Surgical aortic valve replacement was characterized by transient hypofibrinogenemia and von Willebrand factor (vWF) depletion, which quickly recovered within 24 h after AVR. Transcatheter aortic valve implantation was characterized by substantial alteration of platelet function and vWF depletion with significant platelet reactivity impairment and increase in platelet sensitivity to antiplatelet agent, early after the procedure. TAVI-related hemostasis alterations were not recovered at 24 h after the procedure.

Conclusions
Surgical and transcatheter aortic valve replacement procedures are associated with substantial and diverse peri-procedural hemostasis disorders. Since hemostasis disorders related to TAVI are mainly characterized by impaired platelet function, early dual antiplatelet prophylaxis after TAVI requires careful consideration.

keywords:

aortic valve replacement, transcatheter aortic valve implantation, bleeding complications, peri-procedural hemostasis disorders, platelet reactivity

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.